IMM 2.34% 32.8¢ immutep limited

Their products Provenge and CVac are based on similar...

  1. 71 Posts.
    Their products Provenge and CVac are based on similar technologies where the blood of the patient is taken out and treated then put back so that the patient's own body can fight the disease. Provenge is aimed at Prostate cancer and CVac ovarian cancer. Once established as treatments the obvious path is to go for other forms of cancer. Hope this is correct.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
32.8¢
Change
0.008(2.34%)
Mkt cap ! $479.3M
Open High Low Value Volume
32.0¢ 33.3¢ 32.0¢ $575.8K 1.772M

Buyers (Bids)

No. Vol. Price($)
16 177251 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 458273 17
View Market Depth
Last trade - 11.58am 25/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.